Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nemaura Med Inc (NQ: NMRD )

0.2199 -0.0101 (-4.39%)
Streaming Delayed Price Updated: 12:30 PM EST, Dec 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nemaura Med Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Participation at Upcoming H.C. Wainwright Global Investment Conference
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Apple To $185? Here Are 5 Other Price Target Changes For Friday
Keybanc raised the price target on Apple Inc. (NASDAQ: AAPL) from $177 to $185. However, Keybanc analyst Brandon Nispel maintained the stock with an Overweight. Apple shares fell 0.9% to $172.63 in... 
Via Benzinga
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Releases Q1 2023 Report, Notes Purchase Agreement Highlight
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nemaura Medical: Q4 Earnings Insights
Nemaura Medical (NASDAQ:NMRD) reported its Q4 earnings results on Thursday, June 30, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Recap: Nemaura Medical Q1 Earnings
  Nemaura Medical (NASDAQ:NMRD) reported its Q1 earnings results on Monday, August 15, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Nemaura Medical reported... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
  
Via Benzinga
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Featured in Bell2Bell Podcast
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Secures UK Trademark for ‘Meta Score’
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday
Gainers Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Nasdaq Turns Higher; Rubicon Technology Shares Jump
U.S. stocks pared losses toward the end of trading, with the Nasdaq Composite turning higher later on Tuesday. 
Via Benzinga
Tesla, Ra Medical Systems And 51 Stocks Moving In Tuesday's Mid-Day Session
Gainers Ra Medical Systems, Inc. (NASDAQ: RMED) shares jumped 69.6% to $0.5240 after the company announced it has received FDA 510(k) clearance for its DABRA 2.0 catheter. 
Via Benzinga
Nemaura Medical's Return On Capital Employed Insights
Nemaura Medical (NASDAQ:NMRD) brought in sales totaling $320.28 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 5.41%, resulting in a loss of $3.62 million. 
Via Benzinga
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Releases Financial Report, Corporate Updates
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Secures $5M in Non-Dilutive Funding
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Participate in H.C. Wainwright Global Hybrid Investment Conference
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) UK licensee, MySugarWatch, Begins Direct-to-Consumer Campaign in Daily Mail
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Stocks That Hit 52-Week Lows On Friday
On Friday, 153 companies set new 52-week lows. 
Via Benzinga
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Launch of Physician-Focused Ads as Part of Large-Scale Campaign Around sugarBEAT(R)
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Present at Planet MicroCap Showcase 2022
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Nemaura Medical's (NASDAQ: NMRD) Technologies Stand Distinct
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
Nemaura Medical’s (NASDAQ: NMRD) Technologies Stand Distinct
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Technologies Stand Distinct
Via Investor Brand Network
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2022
Upgrades 
Via Benzinga
Nemaura To Participate At Maxim Group Virtual Growth Conference
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a... 
Via Benzinga
Nemaura (NASDAQ: NMRD) to Participate at Maxim Group Virtual Growth Conference
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Participate at Upcoming Maxim Group 2022 Virtual Growth Conference
Via Investor Brand Network
Nemaura Medical Bringing Valuable AI-Powered Insights To Diabetes Market
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
Nemaura Medical (NASDAQ: NMRD) Bringing Valuable AI-Powered Insights to Diabetes Market
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Bringing Valuable AI-Powered Insights to Diabetes Market
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.